Beta Bionics Inc(US:BBNX) Businesswire·2026-01-12 22:45Core Viewpoint - Beta Bionics, Inc. is under investigation for potentially issuing misleading statements and failing to disclose important information to investors, leading to a significant drop in its stock price by approximately 37% [2]. Group 1: Company Overview - Beta Bionics, Inc. is listed on NASDAQ under the ticker BBNX [1]. - The company experienced a sharp decline in its stock price, dropping around 37% on January 9, 2026, following an announcement regarding lower-than-expected patient starts in the fourth quarter [2]. Group 2: Legal Investigation - The investigation by Faruqi & Faruqi, LLP focuses on whether Beta Bionics misled investors or failed to disclose critical information [2]. - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [1].